Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 15 Aug 24 424B3 Prospectus supplement
- 14 Aug 24 424B3 Prospectus supplement
- 1 Jul 24 424B3 Prospectus supplement
- 24 May 24 424B3 Prospectus supplement
- 15 May 24 424B3 Prospectus supplement
- 7 May 24 424B3 Prospectus supplement
- 30 Apr 24 424B3 Prospectus supplement
- 25 Apr 24 EFFECT Notice of effectiveness
- 16 Apr 24 POS AM Prospectus update (post-effective amendment)
- 25 Jan 24 424B3 Prospectus supplement
- 27 Dec 23 EFFECT Notice of effectiveness
- 26 Dec 23 424B3 Prospectus supplement
-
15 Dec 23 S-1 IPO registration
TLSI similar filings
Filing view
External links
Exhibit 23.2
| | |
| KPMG LLP Suite 800 | |
Consent of Independent Registered Public Accounting Firm
We consent to the use of our report dated April 21, 2023, except for Note 2a, as to which the date is December 14, 2023, with respect to the consolidated financial statements of TriSalus Life Sciences, Inc, included herein, and to the reference to our firm under the heading “Experts” in the prospectus.
Denver, Colorado | |
December 14, 2023 | |
KPMG LLP, a Delaware limited liability partnership and a member firm of |